Skip to main content
Top
Published in: Breast Cancer Research and Treatment 1/2014

01-02-2014 | Preclinical Study

α-Parvin, a pseudopodial constituent, promotes cell motility and is associated with lymph node metastasis of lobular breast carcinoma

Authors: Masaoki Ito, Man Hagiyama, Takahiro Mimae, Takao Inoue, Takashi Kato, Azusa Yoneshige, Jun Nakanishi, Tadashi Kondo, Morihito Okada, Akihiko Ito

Published in: Breast Cancer Research and Treatment | Issue 1/2014

Login to get access

Abstract

Invasive lobular carcinoma (ILC) is more frequently lymph node positive than is invasive ductal carcinoma (IDC), and ILC cell infiltration shows distinctive histological characteristics, suggesting the action of ILC-specific invasion molecules. To identify such a molecule, we used a proteomic approach in the pseudopodia of MDA-MB-231 breast cancer cells. A pseudopodial constituent was identified using excimer laser ablation, two-dimensional difference gel electrophoresis, mass spectroscopy, and immunocytofluorescence. MDA-MB-231 cells were modified to express various levels of this constituent by transient transfection and were examined for pseudopodia formation and migratory abilities using wound healing and two-chamber assays. Immunohistochemical positivity of human breast cancer cells (56 ILCs and 21 IDCs) was compared with clinicopathological variables. An actin-binding adaptor protein, α-parvin, was found to localize to pseudopodia and to form focal adhesions in cells not induced to extend pseudopodia. Pseudopodial length and density and migratory abilities correlated with α-parvin expression. Twenty-one (37.5 %) ILCs stained positive for α-parvin, whereas the results were negative for all 21 IDCs (P < 0.001). α-Parvin positivity in ILC was significantly associated with lymphatic invasion (P = 0.038) and lymph node metastasis (P = 0.003) in univariate analyses and to lymph node metastasis (P = 0.020) in multivariate analyses. α-Parvin, a pseudopodial constituent, was found to promote migration of breast cancer cells and to be expressed exclusively by ILC, suggesting that α-parvin is an ILC-specific invasion molecule that may have clinical utility as a biomarker for aggressive subsets of ILC.
Appendix
Available only for authorised users
Literature
1.
go back to reference Lakhani SR, Ellis IO, Schnitt SJ, Tan PH, van de Vijver MJ (2012) WHO Classification of Tumors of the Breast. International Agency for Research on Cancer, Lyon, France Lakhani SR, Ellis IO, Schnitt SJ, Tan PH, van de Vijver MJ (2012) WHO Classification of Tumors of the Breast. International Agency for Research on Cancer, Lyon, France
3.
go back to reference Sørlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H et al (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98(19):10869–10874. doi:10.1073/pnas.191367098 PubMedCrossRef Sørlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H et al (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98(19):10869–10874. doi:10.​1073/​pnas.​191367098 PubMedCrossRef
4.
go back to reference Weigelt B, Horlings HM, Kreike B, Hayes MM, Hauptmann M, Wessels LF et al (2008) Refinement of breast cancer classification by molecular characterization of histological special types. J Pathol 216(2):141–150. doi:10.1002/path.2407 PubMedCrossRef Weigelt B, Horlings HM, Kreike B, Hayes MM, Hauptmann M, Wessels LF et al (2008) Refinement of breast cancer classification by molecular characterization of histological special types. J Pathol 216(2):141–150. doi:10.​1002/​path.​2407 PubMedCrossRef
5.
go back to reference Weigelt B, Geyer FC, Natrajan R, Lopez-Garcia MA, Ahmad AS, Savage K et al (2010) The molecular underpinning of lobular histological growth pattern: a genome-wide transcriptomic analysis of invasive lobular carcinomas and grade- and molecular subtype-matched invasive ductal carcinomas of no special type. J Pathol 220(1):45–57. doi:10.1002/path.2629 PubMedCrossRef Weigelt B, Geyer FC, Natrajan R, Lopez-Garcia MA, Ahmad AS, Savage K et al (2010) The molecular underpinning of lobular histological growth pattern: a genome-wide transcriptomic analysis of invasive lobular carcinomas and grade- and molecular subtype-matched invasive ductal carcinomas of no special type. J Pathol 220(1):45–57. doi:10.​1002/​path.​2629 PubMedCrossRef
6.
go back to reference Lauffenburger DA, Horwitz AF (1996) Cell migration: a physically integrated molecular process. Cell 84(3):359–369PubMedCrossRef Lauffenburger DA, Horwitz AF (1996) Cell migration: a physically integrated molecular process. Cell 84(3):359–369PubMedCrossRef
8.
go back to reference Ito A, Mimae T, Yamamoto YS, Hagiyama M, Nakanishi J, Ito M et al (2012) Novel application for pseudopodia proteomics using excimer laser ablation and two-dimensional difference gel electrophoresis. Lab Invest 92(9):1374–1385. doi:10.1038/labinvest.2012.98 PubMedCrossRef Ito A, Mimae T, Yamamoto YS, Hagiyama M, Nakanishi J, Ito M et al (2012) Novel application for pseudopodia proteomics using excimer laser ablation and two-dimensional difference gel electrophoresis. Lab Invest 92(9):1374–1385. doi:10.​1038/​labinvest.​2012.​98 PubMedCrossRef
10.
go back to reference Nikolopoulos SN, Turner CE (2000) Actopaxin, a new focal adhesion protein that binds paxillin LD motifs and actin and regulates cell adhesion. J Cell Biol 151(7):1435–1448PubMedCrossRef Nikolopoulos SN, Turner CE (2000) Actopaxin, a new focal adhesion protein that binds paxillin LD motifs and actin and regulates cell adhesion. J Cell Biol 151(7):1435–1448PubMedCrossRef
11.
go back to reference Olski TM, Noegel AA, Korenbaum E (2001) Parvin, a 42 kDa focal adhesion protein, related to the alpha-actinin superfamily. J Cell Sci 114(Pt 3):525–538PubMed Olski TM, Noegel AA, Korenbaum E (2001) Parvin, a 42 kDa focal adhesion protein, related to the alpha-actinin superfamily. J Cell Sci 114(Pt 3):525–538PubMed
12.
go back to reference Nikolopoulos SN, Turner CE (2002) Molecular dissection of actopaxin–integrin-linked kinase–Paxillin interactions and their role in subcellular localization. J Biol Chem 277(2):1568–1575PubMedCrossRef Nikolopoulos SN, Turner CE (2002) Molecular dissection of actopaxin–integrin-linked kinase–Paxillin interactions and their role in subcellular localization. J Biol Chem 277(2):1568–1575PubMedCrossRef
13.
go back to reference Yun SP, Ryu JM, Han HJ (2011) Involvement of β1-integrin via PIP complex and FAK/paxillin in dexamethasone-induced human mesenchymal stem cells migration. J Cell Physiol 226(3):683–692. doi:10.1002/jcp.22383 PubMedCrossRef Yun SP, Ryu JM, Han HJ (2011) Involvement of β1-integrin via PIP complex and FAK/paxillin in dexamethasone-induced human mesenchymal stem cells migration. J Cell Physiol 226(3):683–692. doi:10.​1002/​jcp.​22383 PubMedCrossRef
15.
go back to reference Devallière J, Chatelais M, Fitau J, Gérard N, Hulin P, Velazquez L et al (2012) LNK (SH2B3) is a key regulator of integrin signaling in endothelial cells and targets α-parvin to control cell adhesion and migration. FASEB J 26(6):2506–2592. doi:10.1096/fj.11-193383 CrossRef Devallière J, Chatelais M, Fitau J, Gérard N, Hulin P, Velazquez L et al (2012) LNK (SH2B3) is a key regulator of integrin signaling in endothelial cells and targets α-parvin to control cell adhesion and migration. FASEB J 26(6):2506–2592. doi:10.​1096/​fj.​11-193383 CrossRef
16.
go back to reference Clarke DM, Brown MC, LaLonde DP, Turner CE (2004) Phosphorylation of actopaxin regulates cell spreading and migration. J Cell Biol 166(6):901–912PubMedCrossRef Clarke DM, Brown MC, LaLonde DP, Turner CE (2004) Phosphorylation of actopaxin regulates cell spreading and migration. J Cell Biol 166(6):901–912PubMedCrossRef
17.
18.
go back to reference Mimae T, Okada M, Hagiyama M, Miyata Y, Tsutani Y, Inoue T et al (2012) Upregulation of notch2 and six1 is associated with progression of early-stage lung adenocarcinoma and a more aggressive phenotype at advanced stages. Clin Cancer Res 18(4):945–955. doi:10.1158/1078-0432.CCR-11-1946 PubMedCrossRef Mimae T, Okada M, Hagiyama M, Miyata Y, Tsutani Y, Inoue T et al (2012) Upregulation of notch2 and six1 is associated with progression of early-stage lung adenocarcinoma and a more aggressive phenotype at advanced stages. Clin Cancer Res 18(4):945–955. doi:10.​1158/​1078-0432.​CCR-11-1946 PubMedCrossRef
21.
22.
go back to reference Sobin LH, Gospodarowicz MK, Wittekind C (2009) TNM classification of malignant tumours, 7th edn. Wiley-Blackwell Inc., New York Sobin LH, Gospodarowicz MK, Wittekind C (2009) TNM classification of malignant tumours, 7th edn. Wiley-Blackwell Inc., New York
23.
go back to reference Kurosumi M (2007) Immunohistochemical assessment of hormone receptor status using a new scoring system (J-score) in breast cancer. Breast Cancer 14(2):189–193PubMedCrossRef Kurosumi M (2007) Immunohistochemical assessment of hormone receptor status using a new scoring system (J-score) in breast cancer. Breast Cancer 14(2):189–193PubMedCrossRef
24.
go back to reference Wolff AC, Hammond ME, Schwartz JN, Hagerty KL, Allred DC, Cote RJ et al (2007) American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol 25(1):118–145PubMedCrossRef Wolff AC, Hammond ME, Schwartz JN, Hagerty KL, Allred DC, Cote RJ et al (2007) American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol 25(1):118–145PubMedCrossRef
25.
26.
go back to reference van Horssen R, Hollestelle A, Rens JA, Eggermont AM, Schutte M, Ten Hagen TL (2012) E-cadherin promotor methylation and mutation are inversely related to motility capacity of breast cancer cells. Breast Cancer Res Treat 136(2):365–377. doi:10.1007/s10549-012-2261-8 PubMedCrossRef van Horssen R, Hollestelle A, Rens JA, Eggermont AM, Schutte M, Ten Hagen TL (2012) E-cadherin promotor methylation and mutation are inversely related to motility capacity of breast cancer cells. Breast Cancer Res Treat 136(2):365–377. doi:10.​1007/​s10549-012-2261-8 PubMedCrossRef
Metadata
Title
α-Parvin, a pseudopodial constituent, promotes cell motility and is associated with lymph node metastasis of lobular breast carcinoma
Authors
Masaoki Ito
Man Hagiyama
Takahiro Mimae
Takao Inoue
Takashi Kato
Azusa Yoneshige
Jun Nakanishi
Tadashi Kondo
Morihito Okada
Akihiko Ito
Publication date
01-02-2014
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 1/2014
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-014-2859-0

Other articles of this Issue 1/2014

Breast Cancer Research and Treatment 1/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine